Two genes encode factors with NF-kappa B- and H2TF1-like DNA-binding properties.

Por Rustgi, A K, Van 't Veer, L J, Bernards, R
Publicado em 1990

N-myc suppresses major histocompatibility complex class I gene expression through down-regulation of the p50 subunit of NF-kappa B.

Por van 't Veer, L J, Beijersbergen, R L, Bernards, R
Publicado em 1993

Structure and expression of major histocompatibility complex-binding protein 2, a 275-kDa zinc finger protein that binds to an enhancer of major histocompatibility complex class I...

Por van 't Veer, L J, Lutz, P M, Isselbacher, K J, Bernards, R
Publicado em 1992

Marker genes for circulating tumour cells predict survival in metastasized breast cancer patients

Por Weigelt, B, Bosma, A J, Hart, A A M, Rodenhuis, S, van 't Veer, L J
Publicado em 2003

TATA-binding protein and the retinoblastoma gene product bind to overlapping epitopes on c-Myc and adenovirus E1A protein.

Por Hateboer, G, Timmers, H T, Rustgi, A K, Billaud, M, van 't Veer, L J, Bernards, R
Publicado em 1993

E2F-5, a new E2F family member that interacts with p130 in vivo.

Por Hijmans, E M, Voorhoeve, P M, Beijersbergen, R L, van 't Veer, L J, Bernards, R
Publicado em 1995

Molecular cloning and chromosomal assignment of the human homolog of int-1, a mouse gene implicated in mammary tumorigenesis.

Por van 't Veer, L J, van Kessel, A G, van Heerikhuizen, H, van Ooyen, A, Nusse, R
Publicado em 1984

Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple mRNA markers

Por Weigelt, B, Verduijn, P, Bosma, A J, Rutgers, E J, Peterse, H L, van't Veer, L J
Publicado em 2004

Identification of a low-risk subgroup of HER-2-positive breast cancer by the 70-gene prognosis signature

Por Knauer, M, Cardoso, F, Wesseling, J, Bedard, P L, Linn, S C, Rutgers, E J T, van 't Veer, L J
Publicado em 2010

N-ras mutations in human cutaneous melanoma from sun-exposed body sites.

Por van 't Veer, L J, Burgering, B M, Versteeg, R, Boot, A J, Ruiter, D J, Osanto, S, Schrier, P I, Bos, J L
Publicado em 1989

The XPB subunit of repair/transcription factor TFIIH directly interacts with SUG1, a subunit of the 26S proteasome and putative transcription factor.

Por Weeda, G, Rossignol, M, Fraser, R A, Winkler, G S, Vermeulen, W, van 't Veer, L J, Ma, L, Hoeijmakers, J H, Egly, J M
Publicado em 1997

Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-up

Por Olivier, R I, van Beurden, M, Lubsen, M A C, Rookus, M A, Mooij, T M, van de Vijver, M J, van't Veer, L J
Publicado em 2004

A multimarker QPCR-based platform for the detection of circulating tumour cells in patients with early-stage breast cancer

Por Molloy, T J, Devriese, L A, Helgason, H H, Bosma, A J, Hauptmann, M, Voest, E E, Schellens, J H M, van't Veer, L J
Publicado em 2011

Long-term impact of the 70-gene signature on breast cancer outcome

Por Drukker, C. A., van Tinteren, H., Schmidt, M. K., Rutgers, E. J. Th., Bernards, R., van de Vijver, M. J., van’t Veer, L. J.
Publicado em 2014

No common denominator for breast cancer lymph node metastasis

Por Weigelt, B, Wessels, L F A, Bosma, A J, Glas, A M, Nuyten, D S A, He, Y D, Dai, H, Peterse, J L, van't Veer, L J
Publicado em 2005

Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers

Por van Sprundel, T C, Schmidt, M K, Rookus, M A, Brohet, R, van Asperen, C J, Rutgers, E J Th, van‘t Veer, L J, Tollenaar, R A E M
Publicado em 2005

Mammographic screening detects low-risk tumor biology breast cancers

Por Drukker, C. A., Schmidt, M. K., Rutgers, E. J. T., Cardoso, F., Kerlikowske, K., Esserman, L. J., van Leeuwen, F. E., Pijnappel, R. M., Slaets, L., Bogaerts, J., van’t Veer, L. J.
Publicado em 2014

Molecular alterations associated with liver metastases development in colorectal cancer patients

Por Bruin, S C, He, Y, Mikolajewska-Hanclich, I, Liefers, G-J, Klijn, C, Vincent, A, Verwaal, V J, de Groot, K A, Morreau, H, van Velthuysen, M-L F, Tollenaar, R A E M, van ‘t Veer, L J
Publicado em 2011

Optimized outcome prediction in breast cancer by combining the 70-gene signature with clinical risk prediction algorithms

Por Drukker, C. A., Nijenhuis, M. V., Bueno-de-Mesquita, J. M., Retèl, V. P., van Harten, W. H., van Tinteren, H., Wesseling, J., Schmidt, M. K., van’t Veer, L. J., Sonke, G. S., Rutgers, E. J. T., van de Vijver, M. J., Linn, S. C.
Publicado em 2014

PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2

Por Wishart, G C, Bajdik, C D, Dicks, E, Provenzano, E, Schmidt, M K, Sherman, M, Greenberg, D C, Green, A R, Gelmon, K A, Kosma, V-M, Olson, J E, Beckmann, M W, Winqvist, R, Cross, S S, Severi, G, Huntsman, D, Pylkäs, K, Ellis, I, Nielsen, T O, Giles, G, Blomqvist, C, Fasching, P A, Couch, F J, Rakha, E, Foulkes, W D, Blows, F M, Bégin, L R, van't Veer, L J, Southey, M, Nevanlinna, H, Mannermaa, A, Cox, A, Cheang, M, Baglietto, L, Caldas, C, Garcia-Closas, M, Pharoah, P D P
Publicado em 2012